BamSEC and AlphaSense Join Forces
Learn More

Riot Platforms Inc. – Transcripts

NASDAQ: RIOT    
Share price (8/28/26): $18.99    
Market cap (8/28/26): $7.126 billion
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
Earnings Revised 08/10/26 Riot Platforms, Inc., Q2 2026 Earnings Call, Aug 10, 2026 08/10/26
Earnings Revised 06/05/26 Riot Platforms, Inc., Q1 2026 Earnings Call, Apr 30, 2026 04/30/26
Earnings Revised 03/05/26 Riot Platforms, Inc., Q4 2025 Earnings Call, Mar 02, 2026 03/02/26
Other Revised 01/19/26 Riot Platforms, Inc. - Special Call 01/16/26
CY 2025
Earnings Revised 12/02/25 Riot Platforms, Inc., Q3 2025 Earnings Call, Oct 30, 2025 10/30/25
Earnings Revised 10/07/25 Riot Platforms, Inc., Q2 2025 Earnings Call, Jul 31, 2025 07/31/25
Earnings Revised 05/02/25 Riot Platforms, Inc., Q1 2025 Earnings Call, May 01, 2025 05/01/25
Earnings Revised 02/25/25 Riot Platforms, Inc., Q4 2024 Earnings Call, Feb 24, 2025 02/24/25
CY 2024
Earnings Revised 01/16/25 Riot Platforms, Inc., Q3 2024 Earnings Call, Oct 30, 2024 10/30/24
Earnings Revised 08/21/24 Riot Platforms, Inc., Q2 2024 Earnings Call, Jul 31, 2024 07/31/24
Earnings Revised 06/13/24 Riot Platforms, Inc., Q1 2024 Earnings Call, May 01, 2024 05/01/24
CY 2022
Other Revised 07/02/25 Riot Blockchain, Inc. - Special Call 12/14/22
CY 2021
Other Revised 05/27/21 Riot Blockchain, Inc., Whinstone US, Inc. - M&A Call 05/27/21
Other Revised 04/08/21 Riot Blockchain, Inc., Whinstone US, Inc. - M&A Call 04/08/21
CY 2020
Other Revised 11/12/20 Riot Blockchain, Inc. - Shareholder/Analyst Call 11/12/20
CY 2016
Other Revised 09/14/16 BiOptix Inc., Venaxis, Inc. - M&A Call 09/14/16
Other Revised 01/27/16 Strand Life Sciences Private Limited, Venaxis, Inc. - M&A Call 01/27/16
CY 2015
Other Revised 06/24/15 Venaxis, Inc. - Shareholder/Analyst Call 06/24/15
Other Revised 04/07/15 Venaxis, Inc. - Special Call 04/07/15
Other Revised 02/13/15 Venaxis, Inc. - Special Call 02/13/15
CY 2014
Other Revised 12/08/14 Venaxis, Inc. - Special Call 12/08/14
Other Revised 08/11/14 Venaxis, Inc. - Special Call 08/11/14
Other Revised 03/13/14 Venaxis, Inc. - Special Call 03/13/14
CY 2013
Earnings Revised 11/07/13 Venaxis, Inc., Q3 2013 Earnings Call, Nov 07, 2013 11/07/13
Other Revised 07/16/13 Venaxis, Inc. - Special Call 07/16/13
Earnings Revised 03/26/13 Venaxis, Inc., Q4 2012 Earnings Call, Mar 26, 2013 03/26/13
CY 2012
Earnings Revised 11/13/12 AspenBio Pharma, Inc., Q3 2012 Earnings Call, Nov 13, 2012 11/13/12
Other Revised 09/27/12 AspenBio Pharma, Inc. - Special Call 09/27/12
Other Revised 08/15/12 AspenBio Pharma, Inc. - Special Call 08/15/12
CY 2011
Other Revised 11/28/11 AspenBio Pharma, Inc. - Special Call 11/28/11
Other Revised 10/19/11 AspenBio Pharma, Inc. - Shareholder/Analyst Call 10/19/11
CY 2007
Other Revised 05/22/07 AspenBio Pharma Inc. - Conference Presentation Call 05/22/07